| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | HRTG GPE, LLC | 10%+ owner | Buy | 3,125,000 | $16.00 | $50.00M |
| 2026-06-22 | BERNS PAUL L | director, 10%+ owner | Buy | 1,250,000 | $16.00 | $20.00M |
| 2026-06-22 | ARCH Venture Partners XIII, LLC | director, 10%+ owner | Buy | 1,250,000 | $16.00 | $20.00M |
| 2026-06-17 | HRTG GPE, LLC | 10%+ owner | C | 2,050,166 | — | — |
| 2026-06-17 | HRTG GPE, LLC | 10%+ owner | C | 6,150,502 | — | — |
| 2026-06-17 | HRTG GPE, LLC | 10%+ owner | C | 3,242,993 | — | — |
| 2026-06-17 | HRTG GPE, LLC | 10%+ owner | C | 2,348,373 | — | — |
| 2026-06-17 | HRTG GPE, LLC | 10%+ owner | C | 1,287,146 | — | — |
| 2026-06-17 | HRTG GPE, LLC | 10%+ owner | C | 3,861,440 | — | — |
| 2026-06-17 | HRTG GPE, LLC | 10%+ owner | C | 2,036,033 | — | — |
| 2026-06-17 | HRTG GPE, LLC | 10%+ owner | C | 1,474,368 | — | — |
| 2026-06-17 | ARCH Venture Partners XIII, LLC | director, 10%+ owner | C | 13,792,035 | — | — |
| 2026-06-17 | ARCH Venture Partners XIII, LLC | director, 10%+ owner | C | 5,148,587 | — | — |
| 2026-06-17 | ARCH Venture Partners XIII, LLC | director, 10%+ owner | C | 1,204,000 | — | — |
| 2026-06-17 | ARCH Venture Partners XIII, LLC | director, 10%+ owner | C | 2,306,401 | — | — |
| 2026-06-17 | Pasternak Andy | officer | Award | 79,640 | — | — |
| 2026-06-17 | Meeker David P | director | Award | 20,706 | — | — |
| 2026-06-17 | BERNS PAUL L | director, 10%+ owner | C | 13,792,035 | — | — |
| 2026-06-17 | BERNS PAUL L | director, 10%+ owner | Award | 20,706 | — | — |
| 2026-06-17 | BERNS PAUL L | director, 10%+ owner | C | 5,148,587 | — | — |
| 2026-06-17 | BERNS PAUL L | director, 10%+ owner | C | 1,204,000 | — | — |
| 2026-06-17 | BERNS PAUL L | director, 10%+ owner | C | 2,306,401 | — | — |
| 2026-06-17 | Moriarty John B | officer | Award | 47,784 | — | — |
| 2026-06-17 | Jahn Brianne | officer | Award | 79,640 | — | — |
| 2026-06-17 | Popovits Kimberly J | director | Award | 20,706 | — | — |
| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-06-29 | SCHEDULE 13D | ARCH Venture Fund XIII, L.P. | 16.20% | 15,042,035 | view → |
| 2026-06-29 | SCHEDULE 13G | HRTG GPE, LLC | — | — | view → |
| 2026-06-25 | SCHEDULE 13D | PERCEPTIVE ADVISORS LLC | 8.90% | 8,254,144 | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-09-23 | SCHEDULE 13G | Nurix Therapeutics, Inc. | — | — | view → |
| 2026-08-27 | SCHEDULE 13D/A | Immatics N.V. | — | 11,418,016 | view → |
| 2026-08-25 | SCHEDULE 13D/A | LeonaBio, Inc. | 19.99% | 1,889,403 | view → |
| 2026-08-14 | SCHEDULE 13D/A | Nautilus Biotechnology, Inc. | 9.10% | 11,634,211 | view → |
| 2026-08-14 | SCHEDULE 13D/A | Solid Biosciences Inc. | 11.20% | 12,046,579 | view → |
| 2026-07-23 | SCHEDULE 13G | Freenome, Inc. | — | — | view → |
| 2026-07-20 | SCHEDULE 13G | Research Alliance Corporation IV | — | — | view → |
| 2026-06-25 | SCHEDULE 13D | Kardigan, Inc. KARD | 8.90% | 8,254,144 | view → |
| 2026-01-26 | SCHEDULE | TRINITY BIOTECH PLC TRIB | 9.90% | 1,463,058,248 | view → |
| 2026-01-02 | SCHEDULE | MeiraGTx Holdings plc MGTX | 12.90% | 10,441,562 | view → |
| 2025-02-21 | SCHEDULE | Solid Biosciences Inc. SLDB | 15.60% | 11,934,679 | view → |
| 2025-02-14 | SCHEDULE | TRINITY BIOTECH PLC TRIB | 20.90% | 85,800,000 | view → |
| 2025-01-31 | SCHEDULE | Nautilus Biotechnology, Inc. NAUT | 10.00% | 12,594,211 | view → |
| 2023-10-17 | SC | Cerevel Therapeutics Holdings, Inc. | — | — | view → |
| 2023-06-06 | SC | SOLENO THERAPEUTICS INC SLNO | — | — | view → |
| 2023-05-30 | SC | SOLENO THERAPEUTICS INC SLNO | — | — | view → |
| 2023-05-25 | SC | SOLENO THERAPEUTICS INC SLNO | — | — | view → |
| 2023-04-25 | SC | Cerevel Therapeutics Holdings, Inc. | — | — | view → |
| 2022-12-06 | SC | Solid Biosciences Inc. SLDB | — | — | view → |
| 2022-07-01 | SC | Athira Pharma, Inc. LONA | — | — | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →